1015 Walnut Street
Philadelphia, PA 19107
(215) 955-6383
(215) 955-2878 fax
Philadelphia, PA 19107
(215) 955-6383
(215) 955-2878 fax
Most Recent Peer-reviewed Publications
- Circadian Gene Expression and Clinicopathologic Correlates in Pancreatic Cancer
- Serum monocyte chemoattractant protein-1 in pancreatic cancer
- Caveolin-1 promotes pancreatic cancer cell differentiation and restores membranous E-cadherin via suppression of the epithelial-mesenchymal transition
- Tumor-specific expression and alternative splicing of the COL6A3 gene in pancreatic cancer
- Angiotensin II type 2 receptor blockade inhibits fatty acid synthase production through activation of AMP-activated protein kinase in pancreatic cancer cells
- Expression and regulation of nicotine receptor and osteopontin isoforms in human pancreatic ductal adenocarcinoma
- Involvement of Osteopontin in the Matrix-Degrading and Proangiogenic Changes Mediated by Nicotine in Pancreatic Cancer Cells
- Blocking angiotensin ii type 1 receptor triggers apoptotic cell death in human pancreatic cancer cells
- Induction of monocyte chemoattractant protein-1 by nicotine in pancreatic ductal adenocarcinoma cells: Role of osteopontin
- Effects of thymoquinone in the expression of mucin 4 in pancreatic cancer cells: Implications for the development of novel cancer therapies
- Angiotensin II Regulates the expression of monocyte chemoattractant protein-1 in pancreatic cancer cells
- Anti-inflammatory effects of the Nigella sativa seed extract, thymoquinone, in pancreatic cancer cells
- Expression of a prometastatic splice variant of osteopontin, OPNC, in human pancreatic ductal adenocarcinoma
- Induction of osteopontin expression by nicotine and cigarette smoke in the pancreas and pancreatic ductal adenocarcinoma cells
- Expression and regulation of osteopontin in type 1 diabetes.
- Angiotensin II induces vascular endothelial growth factor in pancreatic cancer cells through an angiotensin II type 1 receptor and ERK1/2 signaling
- Antihypertensives as Novel Antineoplastics: Angiotensin-I-Converting Enzyme Inhibitors and Angiotensin II Type 1 Receptor Blockers in Pancreatic Ductal Adenocarcinoma
- Induction of monocyte chemoattractant protein-1 expression by angiotensin II in the pancreatic islets and β-cells
- Osteopontin protects the islets and β-cells from interleukin-1 β-mediated cytotoxicity through negative feedback regulation of nitric oxide
- Osteopontin deficiency impacts the pancreatic Th1/Th2 cytokine profile following multiple low dose streptozotocin-induced diabetes